Abstract
Preanalytic sampling techniques and preparation of tissue specimens strongly influence analytical results in lung tissue diagnostics both on the morphological but also on the molecular level. However, in contrast to analytics where tremendous achievements in the last decade have led to a whole new portfolio of test methods, developments in preanalytics have been minimal. This is specifically unfortunate in lung cancer, where usually only small amounts of tissue are at hand and optimization in all processing steps is mandatory in order to increase the diagnostic yield. In the following, we provide a comprehensive overview on some aspects of preanalytics in lung cancer from the method of sampling over tissue processing to its impact on analytical test results. We specifically discuss the role of preanalytics in novel technologies like next-generation sequencing and in the state-of the-art cytology preparations. In addition, we point out specific problems in preanalytics which hamper further developments in the field of lung tissue diagnostics.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63:11–30
Gellert AR, Rudd RM, Sinha G et al (1982) Fibreoptic bronchoscopy: effect of multiple bronchial biopsies on diagnostic yield in bronchial carcinoma. Thorax 37:684–687
Popovich J Jr, Kvale PA, Eichenhorn MS et al (1982) Diagnostic accuracy of multiple biopsies from flexible fiberoptic bronchoscopy. A comparison of central versus peripheral carcinoma. Am Rev Respir Dis 125:521–523
Hetzel J, Eberhardt R, Herth FJ et al (2012) Cryobiopsy increases the diagnostic yield of endobronchial biopsy: a multicentre trial. Eur Respir J 39:685–690
Laurent F, Latrabe V, Vergier B et al (2000) Percutaneous CT-guided biopsy of the lung: comparison between aspiration and automated cutting needles using a coaxial technique. Cardiovasc Intervent Radiol 23:266–272
Levine MS, Weiss JM, Harrell JH et al (1988) Transthoracic needle aspiration biopsy following negative fiberoptic bronchoscopy in solitary pulmonary nodules. Chest 93:1152–1155
Fassina A, Corradin M, Zardo D et al (2011) Role and accuracy of rapid on-site evaluation of CT-guided fine needle aspiration cytology of lung nodules. Cytopathology 22:306–312
O’Neill AC, McCarthy C, Ridge CA et al (2012) Rapid needle-out patient-rollover time after percutaneous CT-guided transthoracic biopsy of lung nodules: effect on pneumothorax rate. Radiology 262:314–319
Kazerooni EA, Lim FT, Mikhail A et al (1996) Risk of pneumothorax in CT-guided transthoracic needle aspiration biopsy of the lung. Radiology 198:371–375
Khan MF, Straub R, Moghaddam SR et al (2008) Variables affecting the risk of pneumothorax and intrapulmonal hemorrhage in CT-guided transthoracic biopsy. Eur Radiol 18:1356–1363
Shure D, Fedullo PF (1985) Transbronchial needle aspiration in the diagnosis of submucosal and peribronchial bronchogenic carcinoma. Chest 88:49–51
Kacar N, Tuksavul F, Edipoglu O et al (2005) Effectiveness of transbronchial needle aspiration in the diagnosis of exophytic endobronchial lesions and submucosal/peribronchial diseases of the lung. Lung Cancer 50:221–226
Micames CG, McCrory DC, Pavey DA et al (2007) Endoscopic ultrasound-guided fine-needle aspiration for non-small cell lung cancer staging: a systematic review and metaanalysis. Chest 131:539–548
Herth FJ, Krasnik M, Kahn N et al (2010) Combined endoscopic-endobronchial ultrasound-guided fine-needle aspiration of mediastinal lymph nodes through a single bronchoscope in 150 patients with suspected lung cancer. Chest 138:790–794
Fernandez-Villar A, Gonzalez A, Leiro V et al (2006) Effect of different bronchial washing sequences on diagnostic yield in endoscopically visible lung cancer. Arch Bronconeumol 42:278–282
van der Drift MA, van der Wilt GJ, Thunnissen FB et al (2005) A prospective study of the timing and cost-effectiveness of bronchial washing during bronchoscopy for pulmonary malignant tumors. Chest 128:394–400
Mak VH, Johnston ID, Hetzel MR et al (1990) Value of washings and brushings at fibreoptic bronchoscopy in the diagnosis of lung cancer. Thorax 45:373–376
Totsch M, Guzman J, Theegarten D et al (2007) Bronchoalveolar lavage. Pathologe 28:346–353
Thunnissen E, Kerr KM, Herth FJ et al (2012) The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group. Lung Cancer 76:1–18
Thunnissen FB (2003) Sputum examination for early detection of lung cancer. J Clin Pathol 56:805–810
Karahalli E, Yilmaz A, Turker H et al (2001) Usefulness of various diagnostic techniques during fiberoptic bronchoscopy for endoscopically visible lung cancer: should cytologic examinations be performed routinely? Respiration 68:611–614
Govert JA, Kopita JM, Matchar D et al (1996) Cost-effectiveness of collecting routine cytologic specimens during fiberoptic bronchoscopy for endoscopically visible lung tumor. Chest 109:451–456
Lee HS, Lee GK, Kim MS et al (2008) Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer: how many aspirations per target lymph node station? Chest 134:368–374
Stenzinger A, Penzel R, Endris V et al (2013) Molecular diagnostics in pathology. Dtsch Med Wochenschr 138:1061–1068
Wiedorn KH, Olert J, Stacy RA et al (2002) HOPE–a new fixing technique enables preservation and extraction of high molecular weight DNA and RNA of >20 kb from paraffin-embedded tissues. Hepes-glutamic acid buffer mediated organic solvent protection effect. Pathol Res Pract 198:735–740
Staff S, Kujala P, Karhu R et al (2013) Preservation of nucleic acids and tissue morphology in paraffin-embedded clinical samples: comparison of five molecular fixatives. J Clin Pathol 66:807–810
Gundisch S, Schott C, Wolff C et al (2013) The PAXgene® tissue system preserves phosphoproteins in human tissue specimens and enables comprehensive protein biomarker research. PLoS ONE 8:e60638
Paska C, Bogi K, Szilak L et al (2004) Effect of formalin, acetone, and RNAlater fixatives on tissue preservation and different size amplicons by real-time PCR from paraffin-embedded tissue. Diagn Mol Pathol 13:234–240
van Eijsden RG, Stassen C, Daenen L et al (2013) A universal fixation method based on quaternary ammonium salts (RNAlater) for omics-technologies: Saccharomyces cerevisiae as a case study. Biotechnol Lett 35:891–900
Warth A, Muley T, Meister M et al (2012) The novel histologic international association for the study of lung cancer/American thoracic society/European respiratory society classification system of lung adenocarcinoma is a stage-independent predictor of survival. J Clin Oncol 30:1438–1446
Warth A, Muley T, Herpel E et al (2012) Large-scale comparative analyses of immunomarkers for diagnostic subtyping of non-small-cell lung cancer biopsies. Histopathology 61:1017–1025
Warth A, Stenzinger A, Weichert W (2013) Novel morphological and molecular aspects of lung cancer. Pathologe 34:419–428
Schroeder A, Mueller O, Stocker S et al (2006) The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 7:3
Muley T, Herth FJF, Schnabel PA et al (2012) From tissue to molecular phenotyping: pre-analytical requirements Heidelberg experience. Transl Lung Cancer Res 2:111–121
Warth A, Penzel R, Brandt R et al (2012) Optimized algorithm for Sanger sequencing-based EGFR mutation analyses in NSCLC biopsies. Virchows Arch 460:407–414
Endris V, Penzel R, Warth A et al (2013) Molecular diagnostic profiling of lung cancer specimens with a semiconductor-based massive parallel sequencing approach: feasibility, costs, and performance compared with conventional sequencing. J Mol Diagn 15:765–775
Rivera MP, Mehta AC, Wahidi MM (2013) Establishing the diagnosis of lung cancer: diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 143:e142S–e165S
Gompelmann D, Eberhardt R, Herth FJ (2011) Advanced malignant lung disease: what the specialist can offer. Respiration 82:111–123
Herth FJ, Bubendorf L, Gutz S et al (2013) Diagnostic and predictive analyses of cytological specimens of non-small cell lung cancer: strategies and challenges. Pneumologie 67:198–204
Kossakowski CA, Morresi-Hauf A, Schnabel PA et al (2014) Preparation of cell blocks for lung cancer diagnosis and prediction: protocol and experience of a high-volume center. Respiration 87:432–438
Warth A, Bubendorf L, Gutz S et al (2013) Molecular pathological diagnosis in cytopathology of non-small-cell lung cancer. Standardization of specimen processing. Pathologe 34:310–317
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Warth, A., Muley, T., Meister, M., Weichert, W. (2015). Preanalytics in Lung Cancer. In: Dietel, M., Wittekind, C., Bussolati, G., von Winterfeld, M. (eds) Pre-Analytics of Pathological Specimens in Oncology. Recent Results in Cancer Research, vol 199. Springer, Cham. https://doi.org/10.1007/978-3-319-13957-9_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-13957-9_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-13956-2
Online ISBN: 978-3-319-13957-9
eBook Packages: MedicineMedicine (R0)